02 Nov Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial
Posted at 00:00h
in
Authored by: Bernadino JI, Mocroft A., Mallon Patrick W. G., Wallet C, Gerstoft Jan, Russell C, Reiss P. et al.
In: Lancet HIV, 2015
http://www.ncbi.nlm.nih.gov/pubmed/26520926
http://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(15)00181-2/abstract